Azacitidine Injection: Clinical Trials

6 trials of Azacitidine Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 terminated, 1 unknown. 6 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 2, Active not recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 23Terminated 1, Unknown 1, Withdrawn 1

Follow Azacitidine Injection: new trials by email Literature Review of Azacitidine Injection trials Research Report on Azacitidine Injection

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX]
NP137, Azacitidine Injection, Venetoclax - Acute Myeloid Leukemia Refractory
Phase 1 / Phase 2TerminatedCentre Leon Berard12024-09-112025-02-20
Azacytidine During Anti-tuberculosis Therapy
Azacitidine Injection - Tuberculosis, Pulmonary
Phase 1 / Phase 2WithdrawnAndrew Dinardo2022-10-012023-02-08
A Umbrella Study in R/R PTCL Guided by Molecular Subtypes
Azacitidine Injection, Dasatinib, Linperlisib - Peripheral T Cell Lymphoma
Phase 1 / Phase 2UnknownRuijin Hospital1162022-09-302022-11-09
Pharmacokinetics, Tolerability and Safety of NEX-18a
NEX-18a injection, Azacitidine Injection - Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML)
Phase 1CompletedNanexa AB22021-04-272023-10-17
Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation
Vorinostat, Azacitidine Injection - Acute Myeloid Leukemia, Myelodysplastic Syndromes
Phase 1Active not recruitingJohns Hopkins All Children's Hospital152019-05-012026-07-15
Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment
Azacitidine Injection, sodium phenylbutyrate - Lymphoma, Small Intestine Cancer
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins342000-03-012019-01-11

Conditions studied

Leukemia, Myeloid, Acute (3)  ·  Myelodysplastic Syndromes (2)  ·  Burkitt Lymphoma (1)  ·  Hodgkin Disease (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Intraocular Lymphoma (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Leukemia, Myelomonocytic, Juvenile (1)  ·  Lymphoma (1)  ·  Lymphoma, B-Cell, Marginal Zone (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)

Sponsors

Andrew Dinardo (1)  ·  Centre Leon Berard (1)  ·  Johns Hopkins All Children's Hospital (1)  ·  Nanexa AB (1)  ·  Ruijin Hospital (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Countries

United States (3)  ·  China (1)  ·  France (1)  ·  Sweden (1)

Top investigators

Andrew DiNardo (1)  ·  Cassandra Josephson, MD (1)  ·  Michael A. Carducci, MD (1)  ·  Weili Zhao (1)

Results publications

PMID 19789320

NIH funding

P30CA006973 (1), P50CA058236 (1), R01CA075525 (1), U01CA070095 (1)